Vicarious Surgical (NYSE:RBOT – Get Free Report) issued its earnings results on Monday. The company reported ($2.43) EPS for the quarter, beating analysts’ consensus estimates of ($2.69) by $0.26, Zacks reports. The business had revenue of $2.09 million during the quarter. During the same period last year, the business earned ($2.25) EPS.
Vicarious Surgical Trading Down 14.9 %
Shares of RBOT opened at $8.20 on Wednesday. Vicarious Surgical has a 12-month low of $4.27 and a 12-month high of $19.00. The firm has a 50-day moving average price of $12.56 and a 200 day moving average price of $10.60. The firm has a market capitalization of $48.42 million, a P/E ratio of -0.80 and a beta of 1.35.
Analyst Ratings Changes
Separately, Piper Sandler reduced their target price on shares of Vicarious Surgical from $10.50 to $8.50 and set a “neutral” rating for the company in a research report on Tuesday.
About Vicarious Surgical
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Further Reading
- Five stocks we like better than Vicarious Surgical
- Top Stocks Investing in 5G Technology
- 3 Hot Stock Upgrades as Analysts Look Ahead to Q2 Earnings
- 3 Stocks to Consider Buying in October
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- What is a buyback in stocks? A comprehensive guide for investors
- 3 Must-Own Stocks to Build Wealth This Decade
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
